Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Aug;39(8):1691-5.
doi: 10.1128/AAC.39.8.1691.

In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans

M H Nguyen  1 , F Barchiesi, D A McGough, V L Yu, M G Rinaldi
Affiliations

In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans

M H Nguyen et al. Antimicrob Agents Chemother. 1995 Aug.

Abstract

Amphotericin B and fluconazole are current acceptable therapies for cryptococcal meningitis; however, their effect remains suboptimal. The combination of fluconazole and flucytosine has yielded encouraging clinical results in human immunodeficiency virus patients with cryptococcal meningitis. To investigate the biological basis of this finding, we performed in vitro combination testing of fluconazole and flucytosine against 50 clinical strains of Cryptococcus neoformans var. neoformans. Synergy (fractional inhibitory concentration index of < 1.0) was observed in 62% of cases, while antagonism (fractional inhibitory concentration index of > 2.0) was not observed. For cases in which synergy was not achieved (autonomous or additive effects), the beneficial effect of the combination was still seen (i.e., there was still a decrease, although not as dramatic, in the MIC of one or both drugs when used in combination). The in vitro inhibitory action of flucytosine was greatly enhanced by the addition of fluconazole; the flucytosine MICs for Cryptococcus isolates were markedly decreased to concentrations which were severalfold lower than the achievable cerebrospinal fluid flucytosine concentration. On the other hand, the addition of flucytosine did not greatly enhance the in vitro activity of fluconazole if the initial fluconazole MIC for the isolate was > or = 8 micrograms/ml. Controlled clinical studies are warranted to further elucidate the potential utility of fluconazole-flucytosine combination therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clin Infect Dis. 1994 Oct;19(4):741-5 - PubMed
    1. N Engl J Med. 1992 Jan 9;326(2):83-9 - PubMed
    1. J Infect Dis. 1978 Feb;137(2):122-30 - PubMed
    1. Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S318-26 - PubMed
    1. Ann Intern Med. 1990 Aug 1;113(3):183-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources

  NODES
INTERN 1
twitter 2